Poltreg Competitors and Similar CompaniesClear all
Poltreg's competitors and similar companies include BioGenCell, glyscend and Carmot Therapeutics.
 BioGenCell BioGenCell is a company developing a technology platform to creare treatment for blood vessel diseases typical of diabetes complication, smoking and arthrosclerosis. |  Carmot Therapeutics Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer. | |||
Founding Date | Founding Date 2015 | Founding Date 2008 | Founding Date 2014 | Founding Date 2008 |
Type | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Gdańsk, PL HQ Gdańsk, PL | Locations HQ | Locations Baltimore, US HQ Lowell, US | Locations Berkeley, US HQ |
Employees | Employees 5 | Employees 15 | Employees 9 | Employees 109% decrease |
Funding | ||||
Latest funding round | Latest funding round $ 55.5k (about 10 years ago) | Latest funding round $ 16m (about 4 years ago) | Latest funding round $ 20.5m (about 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 55.5k | Total funding raised $ 16m | Total funding raised $ 21m | Total funding raised $ 74.8m |
For sources of this data, please see the company profile
View Company Profiles
BioGenCell
HQ
Employees
15
BioGenCell is a company developing a technology platform to creare treatment for blood vessel diseases typical of diabetes complication, smoking and arthrosclerosis.
View company
glyscend
HQ
Baltimore, US
Employees
9
glyscend is a company that develops a method of treating metabolic diseases.
View companyCarmot Therapeutics
HQ
Berkeley, US
Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.
View company